The aim of this study was to identify potential ovarian stem cells in situ in ovarian sections of women with borderline ovarian cancer or high-grade serous ovarian carcinoma using immunohistochemistry for pluripotency-related NANOG, which is known to be involved in proliferation and self-renewal of pluripotent stem cells [68]. The gene discussed is NANOG; the disease is ovarian serous carcinoma.